Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Fibriquik, bioMeriux, Inc., Box 15969, Durham, North Carolina 27704-0969

FDA Recall Z-0054-05 · Posted 2004-10-28

Recalling FirmbioMerieux
Recall StatusTerminated
Product CodeGJA
Date Initiated2004-08-20
Date Terminated2005-06-09
Product Quantity2406 units

Reason for Recall

Complaints were received from the field regarding prolonged clot times, high control values and erratic results.

Firm Action

Consignees were notified by letter on 8/20/2004.

Root Cause

Other

Distribution Pattern

Nationwide, Australia, Brazil, Canada, China, Japan, Laos, Philippines, UK

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑